Tsukasa Okamoto

Tsukasa Okamoto

Auto-generated profile, based on publicly available information

Tsukasa Okamoto

Department of Respiratory Medicine, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan; Center for Personalized Medicine for Healthy Aging, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in Lung Cancer
Verified
Journal Article
Closed access
YTYuri Tasaka
Yuri Tasaka
THTakayuki Honda
Takayuki Honda
NNNaoki Nishiyama
Naoki Nishiyama
TTToshiharu Tsutsui
Toshiharu Tsutsui
HSHiroaki Saito
Hiroaki Saito
YMYASUNARI MIYAZAKI
YASUNARI MIYAZAKI

1 July 2018 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
PDF file
TOTsukasa Okamoto
Tsukasa Okamoto
SMSusan K. Mathai
Susan K. Mathai
CHCorinne E. Hennessy
Corinne E. Hennessy
LHLaura A. Hancock
Laura A. Hancock
AWAvram D. Walts
Avram D. Walts
DSDavid A. Schwartz
David A. Schwartz
The common gain-of-function MUC5B promoter variant (rs35705950) is the strongest risk factor for the development of idiopathic pulmonary fibrosis (IPF). While the role of complement in IPF is controversial, both MUC5B and the complement system play a role in lung host defense. The aim of this study was to evaluate the relationship between complement component 3 (C3) and MUC5B in patients with IPF and in bleomycin-induced lung injury in mice. To do this, we evaluated C3 gene expression in whole lung tissue from 300 subjects with IPF and 175 healthy controls. Expression of C3 was higher in IPF than healthy controls {1.40-fold increase [95% confidence interval (CI) 1.31–1.50]; P < 0.0001} and even greater among IPF subjects with the highest-risk IPF MUC5B promoter genotype [TT vs. GG = 1.59-fold (95% CI 1.15–2.20); P < 0.05; TT vs. GT = 1.66-fold (95% CI 1.20–2.30); P < 0.05]. Among subjects with IPF, C3 expression was significantly higher in the lung tissue without microscopic honeycombing than in the lung tissue with microscopic honeycombing [1.40-fold increase (95% CI 1.23– 1.59); P < 0.01]. In mice, while bleomycin exposure increased Muc5b protein expression, C3-deficient mice were protected from bleomycin-induced lung injury. In aggregate, our findings indicate that the MUC5B promoter variant is associated with higher C3 expression and suggest that the complement system may contribute to the pathogenesis of IPF.

1 February 2021 in Journal of Infection and Chemotherapy
Verified
Journal Article
Closed access
YIYuki Iijima
Yuki Iijima
TOTsukasa Okamoto
Tsukasa Okamoto
TSTsuyoshi Shirai
Tsuyoshi Shirai
TMTakahiro Mitsumura
Takahiro Mitsumura
RSRie Sakakibara
Rie Sakakibara
YMYASUNARI MIYAZAKI
YASUNARI MIYAZAKI

15 January 2021 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
TYTakashi Yamana
Takashi Yamana
TOTsukasa Okamoto
Tsukasa Okamoto
MIMasahiro Ishizuka
Masahiro Ishizuka
SHSatoshi Hanzawa
Satoshi Hanzawa
MEMasaru Ejima
Masaru Ejima
YMYASUNARI MIYAZAKI
YASUNARI MIYAZAKI
Hypersensitivity pneumonitis (HP) typically presents with interstitial inflammation and granulomas induced by an aberrant immune response to inhaled Ags in sensitized individuals. Although IL-17A is involved in the development of HP, the cellular sources of IL-17A and the mechanisms by which IL-17A contributes to granuloma formation remain unclear. Recent studies report that γδ T cells produce IL-17A and exhibit memory properties in various diseases. Therefore, we focused on IL-17A–secreting memory γδ T cells in the sensitization phase and aimed to elucidate the mechanisms by which IL-17A contributes to granuloma formation in HP. We induced a mouse model of HP using pigeon dropping extract (PDE) in wild-type and IL-17A knockout (IL-17A−/−) mice. IL-17A−/− mice exhibited reduced granulomatous areas, attenuated aggregation of CD11b+ alveolar macrophages, and reduced levels of CCL2, CCL4, and CCL5 in the bronchoalveolar lavage fluid. Among IL-17A+ cells, more γδ T cells than CD4+ cells were detected after intranasal PDE administration. Interestingly, the expansion of IL-17A–secreting Vγ4+ or Vγ1−Vγ4− cells of convalescent mice was enhanced in response to the sensitizing Ag. Additionally, coculture of macrophages with PDE and Vγ4+ cells purified from PDE-exposed convalescent mice produced significantly more IL-17A than coculture with Vγ4+ cells from naive mice. Our findings demonstrate that in the sensitization phase of HP, IL-17A–secreting memory γδ T cells play a pivotal role. Furthermore, we characterized the IL-17A/CCL2, CCL4, CCL5/CD11b+ alveolar macrophage axis, which underlies granuloma formation in HP. These findings may lead to new clinical examinations or therapeutic targets for HP. Key Points IL-17A is produced mainly by γδ T cells in hypersensitivity pneumonitis (HP). The IL-17A/chemokines/CD11b+ alveolar macrophage axis underlies development of HP. Memory responses of γδ T cells are involved in sensitization and development of HP.

1 September 2022 in American Journal of Physiology-Lung Cellular and Molecular Physiology
Verified
Journal Article
Closed access
PDF file
TOTsukasa Okamoto
Tsukasa Okamoto
EDEvgenia Dobrinskikh
Evgenia Dobrinskikh
CHCorinne E. Hennessy
Corinne E. Hennessy
NLNaoko Liu
Naoko Liu
MSMarvin I. Schwarz
Marvin I. Schwarz
DSDavid Albert Schwartz
David Albert Schwartz
Previously we have shown that a gain-of-function MUC5B promoter variant (rs35705950) is the strongest risk factor for the development of idiopathic pulmonary fibrosis. We have also found that Muc5b overexpression reduces mucociliary clearance in mice, potentially leading to recurrent injury to the bronchoalveolar epithelia. Hypersensitivity pneumonitis (HP) is induced by inhalation of numerous causative antigens that may be affected by mucociliary clearance. We conducted this study to determine the role of Muc5b in a mouse model of HP induced by Saccharopolyspora rectivirgula (SR) antigen. We used Muc5b-deficient and wild-type (WT) mice to determine whether Muc5b plays a role in inflammation and fibrosis at 3 and 6 wk in an SR model of HP. We measured cell concentrations and MUC5B expression in whole lung lavage (WLL) and quantified fibrosis using hydroxyproline assay and second harmonic generation. Muc5b expression in WLL fluid was significantly increased in SR-exposed WT mice compared with saline controls. WT mice challenged with SR developed more inflammation and lung fibrosis at 6 wk compared with 3 wk postexposure. Moreover, we found that 6 wk following challenge with SR, Muc5b-deficient mice had less lung inflammation and less lung fibrosis than Muc5b WT mice. Furthermore, Muc5b-deficient mice had significantly lower concentrations of TGF-β1 in the WLL compared with Muc5b WT mice at 6 wk of exposure. Muc5b appears to play a role in fibrosis in the animal model of HP and this may have implications for HP in humans.

1 January 2020 in Respiratory Medicine Case Reports
Verified
Journal Article
Open access
TSTsuyoshi Shirai
Tsuyoshi Shirai
TMTakahiro Mitsumura
Takahiro Mitsumura
KAKei Aoyagi
Kei Aoyagi
TOTsukasa Okamoto
Tsukasa Okamoto
MKMoyu Kimura
Moyu Kimura
YMYasunari Miyazaki
Yasunari Miyazaki
Pneumothorax is a rare but life-threatening complication associated with pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Informed consent was obtained from the patient himself.A 50-year-old man presented with a 9-day history of fever, cough, and dyspnoea. He was diagnosed with coronavirus disease 2019 (COVID-19) pneumonia and was admitted to the Medical Hospital, Tokyo Medical and Dental University. Chest CT showed diffuse patchy ground-glass opacities (GGOs). His state of oxygenation deteriorated, and mechanical ventilation was initiated on day 4 after admission (12th day from onset). He improved gradually and was weaned from ventilation on day 15. Sudden onset of bilateral pneumothorax occurred on day 21 with severe respiratory failure, and chest CT revealed pneumatocele formation on both lower lobes. Pneumothorax is a notable complication in cases of severe COVID-19 pneumonia, especially in those who require positive-pressure ventilation.